We are live on ! Find out more
BIOC

Biocept, Inc.
BIOC

Delisted

BIOC was delisted on the 24th of October, 2023.

Back to rankings

13 hedge funds and large institutions have $218K invested in Biocept, Inc. in 2023 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

126% more capital invested

Capital invested by funds: $96.4K → $218K (+$122K)

50% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 4

18% more funds holding

Funds holding: 11 → 13 (+2)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

Holders
13
Holders Change
+2
Holders Change %
+18.18%
% of All Funds
0.21%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
1
Reduced
1
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Alyeska Investment Group
Alyeska Investment Group
Illinois
+$142K
2
VF
Virtu Financial
New York
+$16.6K
3
TSS
Two Sigma Securities
New York
+$15.3K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$12.7K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$12.5K

Top Sellers

Rank Fund Capital Flow
1
AFM
Anson Funds Management
Texas
-$54.3K
2
BFM
Boothbay Fund Management
New York
-$28.5K
3
TRCT
Tower Research Capital (TRC)
New York
-$1.91K
4
JP Morgan Chase
JP Morgan Chase
New York
-$324

BIOC Hedge Fund Activity: Q3 2023 in Review

13 of the 6,311 institutional investors tracked by Wall St. Rank reported a position in Biocept, Inc. (BIOC) for Q3 2023, worth a combined $218K — up 126% from $96.4K a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new BIOC positions and 4 closed out — a net gain of 2 holders — while 1 added to existing stakes and 1 trimmed.

The largest buyer was Alyeska Investment Group, opening a new position worth an estimated $142K. The largest seller was Anson Funds Management, exiting entirely with an estimated $54.3K sold.

  • 13 institutional investors held Biocept, Inc. (BIOC) as of Q3 2023, up from 11 in Q2 2023.
  • Funds reported $218K of Biocept, Inc. stock for Q3 2023, up 126% quarter-over-quarter.
  • 6 funds opened new Biocept, Inc. positions in Q3 2023 and 4 closed out, a net change of +2 holders.
  • The largest Biocept, Inc. buyer in Q3 2023 was Alyeska Investment Group, an estimated $142K added.
  • The largest Biocept, Inc. seller in Q3 2023 was Anson Funds Management, an estimated $54.3K sold.

Based on aggregated 13F filings for Q3 2023.